<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This paper presents emerging evidence linking visceral <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> and the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> (MetSyn) with <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The link between <z:hpo ids='HP_0001513'>obesity</z:hpo> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> has been clearly identified in a multitude of robust epidemiological studies </plain></SENT>
<SENT sid="2" pm="."><plain>Research is now focusing on the role of visceral adipose tissue in <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e>; as it is recognised as an important metabolic tissue that secretes factors that systemically alter the immunological, metabolic and <z:chebi fb="32" ids="24621">endocrine</z:chebi> milieu </plain></SENT>
<SENT sid="3" pm="."><plain>Excess visceral adipose tissue gives rise to a state of <z:hpo ids='HP_0011010'>chronic</z:hpo> systemic <z:mp ids='MP_0001845'>inflammation</z:mp> with associated <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and dysmetabolism, collectively known as the MetSyn </plain></SENT>
<SENT sid="4" pm="."><plain>Prospective cohort studies have shown associations between visceral <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e>, the MetSyn and increased risk of <z:hpo ids='HP_0003002'>breast cancer</z:hpo>, <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, visceral <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> and the MetSyn have been associated with increased <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumour progression</z:e> and reduced survival </plain></SENT>
<SENT sid="6" pm="."><plain>The mechanisms by which visceral <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> and the MetSyn are thought to promote <z:mp ids='MP_0002006'>tumorigenesis</z:mp> are manifold </plain></SENT>
<SENT sid="7" pm="."><plain>These include alterations in adipokine secretion and cell signalling pathways </plain></SENT>
<SENT sid="8" pm="."><plain>In addition, <z:e sem="disease" ids="C0020459" disease_type="Disease or Syndrome" abbrv="">hyperinsulinaemia</z:e>, subsequent <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and stimulation of the insulin-like growth factor-1 axis have <z:hpo ids='HP_0000001'>all</z:hpo> been linked with visceral <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> and promote <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumour progression</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Furthermore, the abundance of inflammatory cells in visceral adipose tissue, including macrophages and T-cells, create systemic <z:mp ids='MP_0001845'>inflammation</z:mp> and a pro-tumorigenic environment </plain></SENT>
<SENT sid="10" pm="."><plain>It is clear from current research that excess visceral <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> and associated dysmetabolism play a central role in the pathogenesis of certain <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> types </plain></SENT>
<SENT sid="11" pm="."><plain>Further research is required to elucidate the exact mechanisms at play and identify potential targets for intervention </plain></SENT>
</text></document>